Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Flow cytometric detection of most proteins in the cell surface proteome is unaffected by trypsin treatment.

Donnenberg VS, Corselli M, Normolle DP, Meyer EM, Donnenberg AD.

Cytometry A. 2018 Aug 14. doi: 10.1002/cyto.a.23525. [Epub ahead of print]

PMID:
30107080
2.

Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Saloman JL, Singhi AD, Hartman DJ, Normolle DP, Albers KM, Davis BM.

Pancreas. 2018 Aug;47(7):856-863. doi: 10.1097/MPA.0000000000001090.

PMID:
29975347
3.

Location matters in early stage nodal diffuse large B-cell lymphoma.

Lontos K, Tsagianni A, Yuan JM, Normolle DP, Boyiadzis M, Hou JZ, Swerdlow SH, Dorritie KA.

Leuk Lymphoma. 2018 Jun 22:1-4. doi: 10.1080/10428194.2018.1471600. [Epub ahead of print] No abstract available.

PMID:
29932787
4.

Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.

Singh KB, Hahm ER, Rigatti LH, Normolle DP, Yuan JM, Singh SV.

Cancer Prev Res (Phila). 2018 Jun;11(6):337-346. doi: 10.1158/1940-6207.CAPR-17-0389. Epub 2018 Mar 15.

PMID:
29545400
5.

The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity.

Djuric Z, Turgeon DK, Sen A, Ren J, Herman K, Ramaswamy D, Zhao L, Ruffin MT 4th, Normolle DP, Smith WL, Brenner DE.

Cancer Prev Res (Phila). 2017 Dec;10(12):729-737. doi: 10.1158/1940-6207.CAPR-17-0091. Epub 2017 Nov 13.

PMID:
29133307
6.

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.

Overacre-Delgoffe AE, Chikina M, Dadey RE, Yano H, Brunazzi EA, Shayan G, Horne W, Moskovitz JM, Kolls JK, Sander C, Shuai Y, Normolle DP, Kirkwood JM, Ferris RL, Delgoffe GM, Bruno TC, Workman CJ, Vignali DAA.

Cell. 2017 Jun 1;169(6):1130-1141.e11. doi: 10.1016/j.cell.2017.05.005. Epub 2017 May 25.

7.

Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.

Gyanchandani R, Lin Y, Lin HM, Cooper K, Normolle DP, Brufsky A, Fastuca M, Crosson W, Oesterreich S, Davidson NE, Bhargava R, Dabbs DJ, Lee AV.

Clin Cancer Res. 2016 Nov 1;22(21):5362-5369. Epub 2016 May 16.

8.

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.

Van Der Kraak L, Goel G, Ramanan K, Kaltenmeier C, Zhang L, Normolle DP, Freeman GJ, Tang D, Nason KS, Davison JM, Luketich JD, Dhupar R, Lotze MT.

J Immunother Cancer. 2016 Oct 18;4:65. doi: 10.1186/s40425-016-0163-8. eCollection 2016.

9.

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Normolle DP, Connelly AK, Dibridge S, Mason G, Whiteside TL, Okada H.

J Neurooncol. 2016 Dec;130(3):517-527. Epub 2016 Sep 13.

10.

Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane.

Bauman JE, Zang Y, Sen M, Li C, Wang L, Egner PA, Fahey JW, Normolle DP, Grandis JR, Kensler TW, Johnson DE.

Cancer Prev Res (Phila). 2016 Jul;9(7):547-57. doi: 10.1158/1940-6207.CAPR-15-0290. Epub 2016 Jun 23.

11.

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Normolle DP, Connelly AK, Dibridge S, Mason G, Whiteside TL, Okada H.

Neuro Oncol. 2016 Aug;18(8):1157-68. doi: 10.1093/neuonc/now026. Epub 2016 Mar 15.

12.

Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.

Shilkrut M, Sapir E, Hanasoge S, Schipper MJ, Normolle DP, Ben-Josef E, Ensminger W, Lawrence TS, Feng M.

Am J Clin Oncol. 2018 Apr;41(4):326-331. doi: 10.1097/COC.0000000000000276.

PMID:
26886946
13.

Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.

Wonderlich ER, Wu WC, Normolle DP, Barratt-Boyes SM.

J Immunol. 2015 Oct 1;195(7):3284-92. doi: 10.4049/jimmunol.1500683. Epub 2015 Aug 21.

14.

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma.

Pardee AD, Yano H, Weinstein AM, Ponce AA, Ethridge AD, Normolle DP, Vujanovic L, Mizejewski GJ, Watkins SC, Butterfield LH.

J Immunother Cancer. 2015 Jul 21;3:32. doi: 10.1186/s40425-015-0077-x. eCollection 2015.

15.

Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.

Boone BA, Bahary N, Zureikat AH, Moser AJ, Normolle DP, Wu WC, Singhi AD, Bao P, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Zeh HJ 3rd.

Ann Surg Oncol. 2015 Dec;22(13):4402-10. doi: 10.1245/s10434-015-4566-4. Epub 2015 Apr 24.

16.

Biomarkers for personalizing omega-3 fatty acid dosing.

Jiang Y, Djuric Z, Sen A, Ren J, Kuklev D, Waters I, Zhao L, Uhlson CL, Hong YH, Murphy RC, Normolle DP, Smith WL, Brenner DE.

Cancer Prev Res (Phila). 2014 Oct;7(10):1011-22. doi: 10.1158/1940-6207.CAPR-14-0134. Epub 2014 Aug 19.

17.

Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Landreneau RJ, Normolle DP, Christie NA, Awais O, Wizorek JJ, Abbas G, Pennathur A, Shende M, Weksler B, Luketich JD, Schuchert MJ.

J Clin Oncol. 2014 Aug 10;32(23):2449-55. doi: 10.1200/JCO.2013.50.8762. Epub 2014 Jun 30.

18.

VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.

Solomon JD, Heitzer MD, Liu TT, Beumer JH, Parise RA, Normolle DP, Leach DA, Buchanan G, DeFranco DB.

Mol Cancer Res. 2014 Aug;12(8):1166-80. doi: 10.1158/1541-7786.MCR-13-0395. Epub 2014 May 13.

19.

Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.

Stopczynski RE, Normolle DP, Hartman DJ, Ying H, DeBerry JJ, Bielefeldt K, Rhim AD, DePinho RA, Albers KM, Davis BM.

Cancer Res. 2014 Mar 15;74(6):1718-27. doi: 10.1158/0008-5472.CAN-13-2050. Epub 2014 Jan 21.

20.

Concurrent whole brain radiotherapy and bortezomib for brain metastasis.

Lao CD, Friedman J, Tsien CI, Normolle DP, Chapman C, Cao Y, Lee O, Schipper M, Van Poznak C, Hamstra D, Lawrence T, Hayman J, Redman BG.

Radiat Oncol. 2013 Aug 21;8:204. doi: 10.1186/1748-717X-8-204.

21.
22.

Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.

Monaghan SA, Dai L, Mapara MY, Normolle DP, Gollin SM, Lentzsch S.

Leuk Lymphoma. 2013 Sep;54(9):1965-74. doi: 10.3109/10428194.2012.755177. Epub 2013 Jan 28.

23.

A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.

Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1441-7. doi: 10.1016/j.ijrobp.2011.10.020. Epub 2012 Mar 21.

24.

How much pharyngeal exposure is "normal"? Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII).

Hoppo T, Sanz AF, Nason KS, Carroll TL, Rosen C, Normolle DP, Shaheen NJ, Luketich JD, Jobe BA.

J Gastrointest Surg. 2012 Jan;16(1):16-24; discussion 24-5. doi: 10.1007/s11605-011-1741-1. Epub 2011 Oct 28.

25.

Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer.

Zick SM, Turgeon DK, Vareed SK, Ruffin MT, Litzinger AJ, Wright BD, Alrawi S, Normolle DP, Djuric Z, Brenner DE.

Cancer Prev Res (Phila). 2011 Nov;4(11):1929-37. doi: 10.1158/1940-6207.CAPR-11-0224. Epub 2011 Oct 11.

26.

Molecular imaging of akt enables early prediction of response to molecular targeted therapy.

Bhojani MS, Nyati MK, Zhao L, Normolle DP, Ross BD, Lawrence TS, Rehemtulla A.

Transl Oncol. 2011 Jun;4(3):122-5. Epub 2011 Jun 1.

27.

Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial.

Zolotarevsky E, Fehmi SM, Anderson MA, Schoenfeld PS, Elmunzer BJ, Kwon RS, Piraka CR, Wamsteker EJ, Scheiman JM, Korsnes SJ, Normolle DP, Kim HM, Elta GH.

Endoscopy. 2011 Apr;43(4):325-30. doi: 10.1055/s-0030-1256305. Epub 2011 Mar 31.

28.

Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer.

Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, Singh SV.

J Natl Cancer Inst. 2011 Apr 6;103(7):571-84. doi: 10.1093/jnci/djr029. Epub 2011 Feb 17.

29.

Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Maybaum J, Lawrence TS.

Cancer Res. 2010 Jun 15;70(12):4972-81. doi: 10.1158/0008-5472.CAN-09-3573. Epub 2010 May 25.

30.

Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test.

Ruffin MT, Normolle DP, Evelegh MJ, Baron JA, Bresalier RS, Marcon NE, Syngal S, Turgeon DK, Tuck MK, Brenner DE.

Cancer Biomark. 2010-2011;8(2):109-12. doi: 10.3233/CBM-2011-0206.

31.

Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying.

Stoffel EM, Turgeon DK, Stockwell DH, Normolle DP, Tuck MK, Marcon NE, Baron JA, Bresalier RS, Arber N, Ruffin MT, Syngal S, Brenner DE; Great Lakes New England Clinical Epidemiology and Validation Center of the Early Detection Research Network.

Cancer Prev Res (Phila). 2008 Dec;1(7):507-13. doi: 10.1158/1940-6207.CAPR-08-0096.

32.

Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).

Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S; Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network.

Cancer Prev Res (Phila). 2008 Nov;1(6):470-5. doi: 10.1158/1940-6207.CAPR-08-0098.

33.

Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.

Zick SM, Ruffin MT, Lee J, Normolle DP, Siden R, Alrawi S, Brenner DE.

Support Care Cancer. 2009 May;17(5):563-72. doi: 10.1007/s00520-008-0528-8. Epub 2008 Nov 13.

34.

Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects.

Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, Feng MR, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1930-6. doi: 10.1158/1055-9965.EPI-07-2934.

35.

The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.

Morgan MA, Parsels LA, Kollar LE, Normolle DP, Maybaum J, Lawrence TS.

Clin Cancer Res. 2008 Aug 15;14(16):5142-9. doi: 10.1158/1078-0432.CCR-07-4072.

36.

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.

Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7. doi: 10.1158/1055-9965.EPI-07-2693.

37.

Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.

Brenner DE, Normolle DP.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1918-20. No abstract available.

38.

Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.

Desai SP, Ben-Josef E, Normolle DP, Francis IR, Greenson JK, Simeone DM, Chang AE, Colletti LM, Lawrence TS, Zalupski MM.

J Clin Oncol. 2007 Oct 10;25(29):4587-92.

PMID:
17925553
39.

Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.

Feng FY, Lopez CA, Normolle DP, Varambally S, Li X, Chun PY, Davis MA, Lawrence TS, Nyati MK.

Clin Cancer Res. 2007 Apr 15;13(8):2512-8.

40.

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography.

Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA, Brenner DE, Booth TD, Gescher A, Steward WP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):182-7. Epub 2006 Nov 9.

41.

Body mass index predicts the incidence of radiation pneumonitis in breast cancer patients.

Allen AM, Prosnitz RG, Ten Haken RK, Normolle DP, Yu X, Zhou SM, Marsh R, Marks LB, Pierce LJ.

Cancer J. 2005 Sep-Oct;11(5):390-8.

PMID:
16267908
42.

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

Schneider BJ, Ben-Josef E, McGinn CJ, Chang AE, Colletti LM, Normolle DP, Hejna GF, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1325-30. Epub 2005 Jul 1.

PMID:
15993549
43.

Testing new chemoradiation regimens for head-and-neck cancer.

Eisbruch A, Normolle DP.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):5-6. No abstract available.

PMID:
15629586
44.

Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III.

Ruffin MT, Bailey JM, Normolle DP, Michael CW, Bieniasz ME, Kmak DC, Unger ER, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2148-52.

45.
46.

Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis.

Winer I, Normolle DP, Shureiqi I, Sondak VK, Johnson T, Su L, Brenner DE.

Melanoma Res. 2002 Oct;12(5):429-34.

PMID:
12394183
47.

Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques.

Pierce LJ, Butler JB, Martel MK, Normolle DP, Koelling T, Marsh RB, Lichter AS, Fraass BA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1220-30.

PMID:
11955732
48.

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM.

J Clin Oncol. 2002 Mar 15;20(6):1635-42.

PMID:
11896114
49.

Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy.

Madu CN, Quint DJ, Normolle DP, Marsh RB, Wang EY, Pierce LJ.

Radiology. 2001 Nov;221(2):333-9.

PMID:
11687672
50.

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.

Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd RF 3rd, Littles JF, Sullivan MA, Possert PW, Turrisi AT, Lichter AS.

J Clin Oncol. 2001 Jan 1;19(1):127-36.

PMID:
11134205

Supplemental Content

Loading ...
Support Center